Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-01-30

Clinical Trial Update: Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients [NA]

View source ↗

Summary

A completed clinical trial assessing the efficacy of naltrexone as augmentation to SSRI therapy in patients with obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: Sheba Medical Center | Conditions: Obsessive Compulsive Disorder | NA | Status: COMPLETED